Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics

Completed · Phase 1

Conditions studied: Pharmacokinetics

In brief

Evaluate the effect of taking ketoconazole on sufentanil plasma concentrations following sublingual administration of sufentanil NanoTab.

Key facts

Study ID

NCT01721070

Run by

Talphera, Inc

People needed

19

Starts

2012-11-01

Expected to finish

2012-12-01

Last updated by the study team

2016-11-04

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Non smoking
• Ages 18 to 45 year, inclusive
• BMI between 18 and 30

You may not qualify if…

• subjects taking any prescription or OTC medications or vitamins or supplements
• pregnant females
• subjects with pulmonary disease or sleep apnea

Where it is running

• PRA — Lenexa, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.